Findings

What do systematic reviews say?

1 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

SWITCHING ‐ NEW ANTIPSYCHOTIC REGIMEN vs CONTINUATION ON PREVIOUS REGIMEN: 1b. NEW ATYPICAL from OLANZAPINE ‐ medium term (3‐12 months)

Weight (kg) · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems

2 findings from 1 review

Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 287 participants
Low
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 158 participants
Low